Mike Florio and Chris Simms discuss the challenges of going from being a coordinator to a head coach and how there’s a ...

Mike Florio and Chris Simms spell out why Tom Brady has a unique advantage as part owner of the Raiders and a broadcaster and ...

In a report released today, Tim Anderson from Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research ...

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tim ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

At $132 per share, J&J paid a 39% premium on Friday’s closing price of Intra-Cellular, a New York City based biotech that ...

Brandon Johnson often speaks of his concern for the welfare of Chicago’s children, usually in the context of seeking more ...

The failed vote was no surprise; even if the amendment had passed, there would have been a 34-vote hurdle to clear a ...

Legislation championed by Gov. JB Pritzker to strongly regulate hemp sales stalled in the Illinois House late Monday after intense lobbying by both the governor and Mayor Brandon Johnson, who opposed ...

Sales of the weedlike substances have increased, in part thanks to a loophole in federal law, prompting smoke shops that sell ...

JNJ-2056 is under clinical development by Johnson & Johnson Innovative Medicine and currently in Phase II for Tauopathies.